Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Disease Progression in Patients With Primary Focal Segmental Glomerulosclerosis

NCT03126201 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.

NCT NCT03126201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03126201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Disease Progression in Patients With Primary Focal Segmental Glomerulosclerosis
Lead sponsor
Istanbul University
Phase
Observational
Overall status
Completed
Start date
December 31, 2016
Completion date
November 30, 2017
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

focal segmental glomerulosclerosis, glomerulonephritis